Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0PJPNC
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
APLP2/HER2 antibody-drug conjugate
|
|||||
| Synonyms |
APLP2 x HER2 antibody-drug conjugate (Regeneron)
Click to Show/Hide
|
|||||
| Organization |
Regeneron Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Gastric cancer [ICD11:2B72]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Amyloid beta precursor like protein 2 (APLP2); Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Mertansine DM1
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.